SG Americas Securities LLC Sells 5,178 Shares of SI-BONE, Inc. (NASDAQ:SIBN)

SG Americas Securities LLC decreased its stake in shares of SI-BONE, Inc. (NASDAQ:SIBN) by 20.5% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 20,054 shares of the company’s stock after selling 5,178 shares during the period. SG Americas Securities LLC’s holdings in SI-BONE were worth $281,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. FMR LLC increased its position in shares of SI-BONE by 103.6% during the third quarter. FMR LLC now owns 2,354 shares of the company’s stock valued at $33,000 after buying an additional 1,198 shares during the period. Walleye Capital LLC bought a new stake in SI-BONE during the 3rd quarter worth approximately $144,000. The Manufacturers Life Insurance Company lifted its stake in SI-BONE by 7.5% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 15,880 shares of the company’s stock worth $205,000 after purchasing an additional 1,105 shares in the last quarter. Squarepoint Ops LLC purchased a new stake in SI-BONE in the 2nd quarter worth approximately $252,000. Finally, Franklin Resources Inc. boosted its holdings in SI-BONE by 9.4% in the 3rd quarter. Franklin Resources Inc. now owns 20,220 shares of the company’s stock valued at $265,000 after purchasing an additional 1,745 shares during the period. Institutional investors own 98.11% of the company’s stock.

Insider Buying and Selling at SI-BONE

In related news, insider Anthony J. Recupero sold 3,937 shares of the stock in a transaction on Monday, November 18th. The shares were sold at an average price of $12.60, for a total transaction of $49,606.20. Following the transaction, the insider now owns 228,554 shares of the company’s stock, valued at approximately $2,879,780.40. This trade represents a 1.69 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Laura Francis sold 10,048 shares of SI-BONE stock in a transaction on Monday, November 18th. The stock was sold at an average price of $12.58, for a total transaction of $126,403.84. Following the completion of the transaction, the chief executive officer now owns 482,875 shares in the company, valued at approximately $6,074,567.50. The trade was a 2.04 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 27,344 shares of company stock worth $357,292 over the last 90 days. Corporate insiders own 3.90% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently weighed in on SIBN. Truist Financial upped their price target on shares of SI-BONE from $16.00 to $18.00 and gave the stock a “buy” rating in a report on Wednesday, November 13th. Needham & Company LLC restated a “buy” rating and issued a $19.00 target price on shares of SI-BONE in a research note on Monday, January 13th. Six equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $23.00.

SI-BONE Stock Performance

NASDAQ SIBN opened at $18.10 on Thursday. SI-BONE, Inc. has a 52-week low of $11.70 and a 52-week high of $21.64. The company has a fifty day moving average of $14.80 and a 200-day moving average of $14.52. The company has a market capitalization of $759.11 million, a P/E ratio of -19.67 and a beta of 1.17. The company has a debt-to-equity ratio of 0.22, a quick ratio of 7.22 and a current ratio of 8.25.

SI-BONE Company Profile

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.